171 related articles for article (PubMed ID: 17203867)
1. Physicochemical and microbiological properties of eye drops containing cefuroxime.
Kodym A; Zawisza T; Taberska J; Kukuła H
Acta Pol Pharm; 2006; 63(4):293-9. PubMed ID: 17203867
[TBL] [Abstract][Full Text] [Related]
2. Influence of additives and storage temperature on physicochemical and microbiological properties of eye drops containing cefazolin.
Kodym A; Zawisza T; Buźka K; Kukuła H
Acta Pol Pharm; 2006; 63(3):225-34. PubMed ID: 20085229
[TBL] [Abstract][Full Text] [Related]
3. Influence of additives and storage temperature on physicochemical and microbiological properties of eye drops containing ceftazidime.
Kodym A; Zawisza T; Napierała B; Kukuła H
Acta Pol Pharm; 2006; 63(6):507-13. PubMed ID: 17438868
[TBL] [Abstract][Full Text] [Related]
4. Stability of cefuroxime in 1% and 5% buffered eye drops determined with HPLC method.
Kodym A; Wiśniewski A; Knioła D; Olejniczak M
Acta Pol Pharm; 2011; 68(4):555-64. PubMed ID: 21796938
[TBL] [Abstract][Full Text] [Related]
5. Technology of eye drops containing aloe (Aloe arborescens Mill.--Liliaceae) and eye drops containing both aloe and neomycin sulphate.
Kodym A; Marcinkowski A; Kukuła H
Acta Pol Pharm; 2003; 60(1):31-9. PubMed ID: 12848365
[TBL] [Abstract][Full Text] [Related]
6. Physical and chemical properties and stability of sodium cefazolin in buffered eye drops determined with HPLC method.
Kodym A; Bilski P; Domańska A; Hełminiak Ł; Jabłońska M; Jachymska A
Acta Pol Pharm; 2012; 69(1):95-105. PubMed ID: 22574512
[TBL] [Abstract][Full Text] [Related]
7. Stability of ceftazidime in 1% and 5% buffered eye drops determined with HPLC method.
Kodym A; Hapka-Zmich D; Gołab M; Gwizdala M
Acta Pol Pharm; 2011; 68(1):99-107. PubMed ID: 21485707
[TBL] [Abstract][Full Text] [Related]
8. Technology of eye drops containing metronidazole.
Kodym A; Kaczyńska-Dyba E; Kubiak B; Kukuła H
Acta Pol Pharm; 2011; 68(1):109-14. PubMed ID: 21485708
[TBL] [Abstract][Full Text] [Related]
9. Stability of cefepime in aqueous eye drops.
Kodym A; Pawłowska M; Rumiński JK; Bartosińska A; Kieliba A
Pharmazie; 2011 Jan; 66(1):17-23. PubMed ID: 21391430
[TBL] [Abstract][Full Text] [Related]
10. Microemulsions with timolol as potential eye drops.
Malina I; Radomska-Soukharev A
Pharmazie; 2006 Jul; 61(7):650-1. PubMed ID: 16889077
[TBL] [Abstract][Full Text] [Related]
11. Temperature-mediated absorption of phenylmercuric nitrate on polyethylene and polypropylene containers in chloramphenicol eye drops.
Charoo N; Chiew M; Tay A; Lian L
Cutan Ocul Toxicol; 2014 Sep; 33(3):242-6. PubMed ID: 24147942
[TBL] [Abstract][Full Text] [Related]
12. Preservative efficacy in cefuroxime and ceftazidime eye drop formulations.
Barnes AR; Nash S
J Clin Pharm Ther; 1994 Oct; 19(5):327-32. PubMed ID: 7806604
[TBL] [Abstract][Full Text] [Related]
13. [Antimicrobial agents in eyedrops].
Sklubalová Z
Ceska Slov Farm; 2004 May; 53(3):107-16. PubMed ID: 15218731
[TBL] [Abstract][Full Text] [Related]
14. A method for the obtaining of increased viscosity eye drops containing amikacin.
Sikora A; Oszczapowicz I; Tejchman B; Grzechnik M
Acta Pol Pharm; 2005; 62(1):31-7. PubMed ID: 16022491
[TBL] [Abstract][Full Text] [Related]
15. [Development of formulation of hipromellose eye drops (artificial tears)].
Inkeniene AM; Klimas R; Briedis V; Maciulevicius J
Medicina (Kaunas); 2003; 39(1):77-82. PubMed ID: 12576769
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial Effectiveness in Eye Drops: Limited Sterility versus Reduction in Microbial Count.
Abu Shaqra QM; Al-Groom RM; Abu Shaqra AQ
PDA J Pharm Sci Technol; 2020; 74(3):309-317. PubMed ID: 31941794
[TBL] [Abstract][Full Text] [Related]
17. Stability of cefazolin sodium eye drops.
How TH; Loo WY; Yow KL; Lim LY; Chan EW; Ho PC; Chan SY
J Clin Pharm Ther; 1998 Feb; 23(1):41-7. PubMed ID: 9756111
[TBL] [Abstract][Full Text] [Related]
18. Formulation and in vitro evaluation of cysteamine hydrochloride viscous solutions for the treatment of corneal cystinosis.
Bozdağ S; Gümüş K; Gümüş O; Unlü N
Eur J Pharm Biopharm; 2008 Sep; 70(1):260-9. PubMed ID: 18590953
[TBL] [Abstract][Full Text] [Related]
19. Local Ugandan Production of Stable 0.2% Chlorhexidine Eye Drops.
Picken CAR; Brocchini S; Burton MJ; Blundell-Hunter G; Kuguminkiriza D; Kaur H; Hoffman JJ; Arunga S; Mohamed-Ahmed AHA
Transl Vis Sci Technol; 2023 Jan; 12(1):27. PubMed ID: 36705928
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial activity of a new preservative for multiuse ophthalmic solutions.
Ghelardi E; Celandroni F; Gueye SA; Salvetti S; Campa M; Senesi S
J Ocul Pharmacol Ther; 2013; 29(6):586-90. PubMed ID: 23428175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
